Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-06

Clinical Trial Update: Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the impact of eHealth support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palbociclib (palbociclib)

Snippet

Sponsor: Palleos Healthcare GmbH | Conditions: Breast Neoplasm | Phase 4 | Status: TERMINATED